HomeTRML • NASDAQ
add
Tourmaline Bio Inc
Previous close
$20.00
Day range
$18.97 - $20.21
Year range
$12.12 - $48.26
Market cap
505.16M USD
Avg Volume
184.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.44M | 267.88% |
Net income | -20.18M | -260.88% |
Net profit margin | — | — |
Earnings per share | -0.78 | 55.88% |
EBITDA | -24.43M | -268.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 281.92M | 261.24% |
Total assets | 328.45M | 285.80% |
Total liabilities | 7.38M | 54.70% |
Total equity | 321.07M | — |
Shares outstanding | 25.64M | — |
Price to book | 1.60 | — |
Return on assets | -18.15% | — |
Return on capital | -18.51% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.18M | -260.88% |
Cash from operations | -23.44M | -334.47% |
Cash from investing | -11.70M | -68,694.12% |
Cash from financing | -1.00K | 99.97% |
Net change in cash | -35.14M | -288.89% |
Free cash flow | -15.93M | -208.41% |
About
Founded
2021
Website
Employees
74
